Receptors

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Discovery of key gene for bone development that when mutated lead to dwarfism

Published July 9, 2009, 12:49 pm, News-Medical-Net

Scientists have just discovered the gene behind Recessive Omodysplasia, a rare skeletal disease characterised by short-limbed dwarfism and craniofacial anomalies.

Discover News | Full Story


Study may lead to new drugs to treat cough

Published July 9, 2009, 12:49 pm, News-Medical-Net

Scientists investigating the cough reflex have discovered a new group of molecules on the surface of nerve cells that make us cough when irritated.

Discover News | Full Story


Take the ‘Slap’ Out of Bug Season

Published July 9, 2009, 12:44 pm, RISMedia Real Estate News

RISMEDIA, July 10, 2009-(MCT)-If you've been out camping, fishing or working in the garden, then chances are you've been smacking, slapping and itching. Mosquitoes, those (bleeping) bloodthirsty spoilers of outdoor summer fun - and their biting friends, black flies, gnats and no-see-ums - are busily, buzzily feasting upon us. The standard ...

Discover News | Full Story


Research Report: Key trigger in lupus identified

Published July 9, 2009, 11:02 am, Del Mar Times

More than 1.5 million Americans have lupus, an autoimmune disease in which the normal chain of events leading to protective antibody production in the body goes awry leading to painful or swollen joints, extreme fatigue, skin rashes, fever and kidney problems. Helping to unravel this mystery, researchers at The Scripps Research Institute report three proteins, so-called Toll-like receptors ...

Discover News | Full Story


Targacept Announces Decision By AstraZeneca To Advance AZD3480 Program In ADHD

Published July 9, 2009, 10:14 am, Medical News Today

Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), announced that AstraZeneca has informed Targacept that it plans to conduct further development of AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million milestone payment to Targacept.

Discover News | Full Story


Study 'confirms' umami taste receptor

Published July 9, 2009, 9:45 am, Food Navigator USA

Findings published by Monell Center scientists in the American Journal of Clinical Nutrition also indicate that variations in the genes that code for the proteins T1R1 and T1R3 correspond to individual variation in sensitivity to the perceived intensity of umami taste.

Discover News | Full Story


Racial Disparities In Breast Cancer Mortality Are Not Driven By Estrogen Receptor Status Alone

Published July 9, 2009, 9:16 am, Medical News Today

Black women who are diagnosed with breast cancer have a higher probability of dying from the disease than white women, regardless of their estrogen receptor status, according to research from the National Cancer Institute (NCI), part of the National Institutes of Health.

Discover News | Full Story


Soy may help men remember anniversaries: Study

Published July 9, 2009, 8:57 am, Nutraingredients.com

Researchers, led by Peter Howe, recruited 34 healthy men to participate in their 12-week double-blind, placebo-controlled cross-over trial. The men were randomly assigned to receive a daily dose of 116 mg soy isoflavones, providing 68 mg daidzein, 12 mg genistein, and 36 mg glycitin, or placebo for 6 weeks.

Discover News | Full Story


Sweetness Perception May Vary with Ethnicity

Published July 9, 2009, 7:56 am, Beverage World

Researchers claim to have discovered a particular gene variant that could affect sweetness perception among different ethnic groups, raising the possibility of more targeted flavor profiling of foods.

Discover News | Full Story


AngioChem Granted First U.S. Patent Covering Angiopep-2, an Engineered Peptide for Drugs to Cross the Blood-Brain ...

Published July 9, 2009, 6:39 am, Marketwire

MONTREAL, CANADA--(Marketwire - July 9, 2009) - AngioChem, a biotechnology company discovering and developing drugs that are uniquely capable of crossing the blood-brain barrier, announced today that its first patent has been granted by the U.S. Patent and Trademark office. U.S. Patent Number 7,557,182 is entitled "Aprotinin polypeptides for transporting a compound across the blood-brain ...

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a